van der Ley P, Kramer M, Martin A, Richards J C, Poolman J T
Laboratory of Vaccine Development and Immune Mechanisms, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
FEMS Microbiol Lett. 1997 Jan 15;146(2):247-53. doi: 10.1111/j.1574-6968.1997.tb10201.x.
By deletion mutagenesis in the entire meningococcal chromosome, we have previously identified the icsA gene, which encodes the glycosyltransferase required for adding GlcNAc to Hep-II in the inner core of meningococcal LPS. This gene has homology to several LPS glycosyltransferases, notably to rfaK from Salmonella typhimurium and bplH from Bordetella pertussis, both of which encode GlcNAc transferases. Directly upstream of icsA is an ORF showing significant homology to the hypothetical protein HI0653 from the Haemophilus influenzae genome sequence, and to a lesser degree to putative glycosyltransferases from Streptococcus thermophilus and Yersinia enterocolitica. Insertional inactivation of this ORF resulted in a meningococcal strain with truncated LPS. We have named this new LPS-involved gene icsB. Differences in binding of monoclonal antibodies and in mobility on Tricine-SDS-PAGE showed that LPS from icsA and icsB mutants is similar but not identical. On the basis of these results, we postulated that the new gene encodes the glycosyltransferase required for adding Glc to Hep-I. Structural analysis of purified mutant LPS by electrospray mass spectrometry was used to verify this hypothesis. The composition determined for icsA and icsB is lipidA-(KDO)2-(Hep)2.PEA and lipidA-(KDO)2-(Hep)2.PEA-GlcNAc, respectively. The icsA and icsB genes thus form an operon encoding the glycosyltransferases required for chain elongation from the lipidA-(KDO)2-(Hep)2 basal structure, with IcsA first adding GlcNAc to Hep-II and IcsB subsequently adding Glc to Hep-I. Only then is completion of the lacto-N-neotetraose structure possible through the action of the IgtA-E genes.
通过对整个脑膜炎球菌染色体进行缺失诱变,我们先前已鉴定出icsA基因,该基因编码在脑膜炎球菌脂多糖(LPS)内核中将N-乙酰葡糖胺(GlcNAc)添加到 Hep-II 所需的糖基转移酶。该基因与几种LPS糖基转移酶具有同源性,特别是与鼠伤寒沙门氏菌的rfaK和百日咳博德特氏菌的bplH同源,这两种酶都编码GlcNAc转移酶。icsA的直接上游是一个开放阅读框(ORF),它与流感嗜血杆菌基因组序列中的假设蛋白HI0653具有显著同源性,并且与嗜热链球菌和小肠结肠炎耶尔森氏菌的推定糖基转移酶有较小程度的同源性。该ORF的插入失活导致了一株LPS截短的脑膜炎球菌菌株。我们将这个新的与LPS相关的基因命名为icsB。单克隆抗体结合以及在Tricine-SDS-PAGE上迁移率的差异表明,来自icsA和icsB突变体的LPS相似但不完全相同。基于这些结果,我们推测新基因编码将Glc添加到Hep-I所需的糖基转移酶。通过电喷雾质谱对纯化的突变体LPS进行结构分析以验证这一假设。确定的icsA和icsB的组成分别是脂多糖A-(KDO)2-(Hep)2.PEA和脂多糖A-(KDO)2-(Hep)2.PEA-GlcNAc。因此,icsA和icsB基因形成一个操纵子,编码从脂多糖A-(KDO)2-(Hep)2基础结构进行链延伸所需的糖基转移酶,其中IcsA首先将GlcNAc添加到Hep-II,随后IcsB将Glc添加到Hep-I。只有这样,通过IgtA-E基因的作用才有可能完成乳糖-N-新四糖结构。